
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study
Ángel Paternina‐Caicedo, Mark Jit, Nelson Alvis‐Guzmán, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100296-100296
Open Access | Times Cited: 18
Ángel Paternina‐Caicedo, Mark Jit, Nelson Alvis‐Guzmán, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100296-100296
Open Access | Times Cited: 18
Showing 18 citing articles:
The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case–control study
Rebecca Kahn, Cara Bess Janusz, Márcia C. Castro, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100474-100474
Open Access | Times Cited: 22
Rebecca Kahn, Cara Bess Janusz, Márcia C. Castro, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100474-100474
Open Access | Times Cited: 22
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection
Fan Zhou, Juha Vahokoski, Siri Øyen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Fan Zhou, Juha Vahokoski, Siri Øyen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
COVID-19 Vaccines: An Updated Overview of Different Platforms
D.А. Kudlаy, Andrey Svistunov, Олег Викторович Сатышев
Bioengineering (2022) Vol. 9, Iss. 11, pp. 714-714
Open Access | Times Cited: 19
D.А. Kudlаy, Andrey Svistunov, Олег Викторович Сатышев
Bioengineering (2022) Vol. 9, Iss. 11, pp. 714-714
Open Access | Times Cited: 19
Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Metabolic Adaptations Correlated with Antibody Response after Immunization with Inactivated SARS-CoV-2 in Brazilian Subjects
Jeane de Souza Nogueira, Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 6, pp. 1908-1922
Closed Access | Times Cited: 2
Jeane de Souza Nogueira, Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 6, pp. 1908-1922
Closed Access | Times Cited: 2
Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey
Süleyman Yıldırım, Erdem Erkoyun, Özcan Alpdoğan, et al.
Journal of Infection and Chemotherapy (2023) Vol. 29, Iss. 10, pp. 959-964
Open Access | Times Cited: 2
Süleyman Yıldırım, Erdem Erkoyun, Özcan Alpdoğan, et al.
Journal of Infection and Chemotherapy (2023) Vol. 29, Iss. 10, pp. 959-964
Open Access | Times Cited: 2
Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak
Wenjing Ye, Kangguo Li, Zeyu Zhao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Wenjing Ye, Kangguo Li, Zeyu Zhao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Real-world effectiveness of the CoronaVac vaccine in a retrospective population-based cohort in four Colombian Cities 2021-2022
Carlos Reina, María Patricia Arbeláez, Hugo Brango, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107156-107156
Open Access
Carlos Reina, María Patricia Arbeláez, Hugo Brango, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107156-107156
Open Access
Factors influencing individual vaccine preferences for COVID‐19 in the Sunyani Municipality, Ghana: An observational study using discrete choice experiment analysis
Samuel Fosu Gyasi, Williams Kumi, Charles Kwofie
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Samuel Fosu Gyasi, Williams Kumi, Charles Kwofie
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Eventos adversos de vacunas contra la COVID-19 en un servicio médico universitario de Bogotá, Colombia
Claudia Patricia Vaca González, Juanita Vahos Zambrano, Sergio Páez, et al.
Revista de la Facultad de Medicina (2024) Vol. 72, Iss. 2, pp. e111722-e111722
Open Access
Claudia Patricia Vaca González, Juanita Vahos Zambrano, Sergio Páez, et al.
Revista de la Facultad de Medicina (2024) Vol. 72, Iss. 2, pp. e111722-e111722
Open Access
Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer.
PubMed (2023) Vol. 26, Iss. 3, pp. 165-176
Closed Access
PubMed (2023) Vol. 26, Iss. 3, pp. 165-176
Closed Access
Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant
Hao Wang, Li Liu, Tangchun Wu
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 576-580
Closed Access
Hao Wang, Li Liu, Tangchun Wu
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 576-580
Closed Access
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test-negative design
Sandra Irala, Sarah Hamid, Elena Penayo, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6453-6460
Closed Access
Sandra Irala, Sarah Hamid, Elena Penayo, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6453-6460
Closed Access
The impact of ageing on SARS-CoV-2 and human coronavirus reactive antibodies after COVID-19 vaccination or infection
Fan Zhou, Juha Vahokoski, Nina Langeland, et al.
Research Square (Research Square) (2023)
Open Access
Fan Zhou, Juha Vahokoski, Nina Langeland, et al.
Research Square (Research Square) (2023)
Open Access
Therapeutic Modalities for Coronavirus SARS-CoV-2 (COVID-19)
Lydia Schmelling, Artur Manasyan, Gabriella Castranova, et al.
Advances in Hematology and Oncology Research (2022) Vol. 5, Iss. 1
Open Access
Lydia Schmelling, Artur Manasyan, Gabriella Castranova, et al.
Advances in Hematology and Oncology Research (2022) Vol. 5, Iss. 1
Open Access
Retrospective Analysis of COVID-19 Vaccination in a University Hospital and the Relationship with the Epidemic Rate
Işıl Deniz Alıravcı, Fatma Gümüşer, Alper Şener
Jurnal Profesi Medika Jurnal Kedokteran dan Kesehatan (2022) Vol. 16, Iss. 2
Open Access
Işıl Deniz Alıravcı, Fatma Gümüşer, Alper Şener
Jurnal Profesi Medika Jurnal Kedokteran dan Kesehatan (2022) Vol. 16, Iss. 2
Open Access